156 related articles for article (PubMed ID: 31171381)
1. A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
Pinsolle J; Mondet J; Duruisseaux M; d'Alnoncourt S; Magnat N; de Fraipont F; Moro-Sibilot D; Toffart AC; Brambilla E; McLeer-Florin A
Clin Lung Cancer; 2019 Sep; 20(5):e535-e540. PubMed ID: 31171381
[No Abstract] [Full Text] [Related]
2. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
Vendrell JA; Taviaux S; Béganton B; Godreuil S; Audran P; Grand D; Clermont E; Serre I; Szablewski V; Coopman P; Mazières J; Costes V; Pujol JL; Brousset P; Rouquette I; Solassol J
Sci Rep; 2017 Oct; 7(1):12510. PubMed ID: 28970558
[TBL] [Abstract][Full Text] [Related]
3. 5'/ 3' imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer.
Tong Y; Zhao Z; Liu B; Bao A; Zheng H; Gu J; McGrath M; Xia Y; Tan B; Song C; Li Y
J Exp Clin Cancer Res; 2018 Mar; 37(1):68. PubMed ID: 29587818
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene].
Yuan Y; Wang Z; Nie X; Zhang P; Li L
Zhongguo Fei Ai Za Zhi; 2022 Sep; 25(9):696-700. PubMed ID: 36172736
[TBL] [Abstract][Full Text] [Related]
5. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
[TBL] [Abstract][Full Text] [Related]
6. CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
Zhang M; Wang Q; Ding Y; Wang G; Chu Y; He X; Wu X; Shao YW; Lu K
J Thorac Oncol; 2018 Nov; 13(11):1792-1797. PubMed ID: 30010043
[TBL] [Abstract][Full Text] [Related]
7. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M
BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis.
Zhao R; Zhang J; Han Y; Shao J; Zhu L; Xiang C; Zhang Q; Teng H; Qin G; Zhao L; Ye M; Zhao J; Ding W
Mol Diagn Ther; 2019 Jun; 23(3):395-405. PubMed ID: 30840206
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy.
Ding M; Deng L; Yu R; Lu D; Bai Y; Wu X; Shao YW; Yang Y
Clin Lung Cancer; 2019 May; 20(3):e229-e232. PubMed ID: 30948231
[No Abstract] [Full Text] [Related]
10. Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants.
Li Y; Zhang T; Zhang J; Li W; Yuan P; Xing P; Zhang Z; Chuai S; Li J; Ying J
Lung Cancer; 2018 Apr; 118():128-133. PubMed ID: 29571990
[TBL] [Abstract][Full Text] [Related]
11. The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Izumi H; Matsumoto S; Liu J; Tanaka K; Mori S; Hayashi K; Kumagai S; Shibata Y; Hayashida T; Watanabe K; Fukuhara T; Ikeda T; Yoh K; Kato T; Nishino K; Nakamura A; Nakachi I; Kuyama S; Furuya N; Sakakibara-Konishi J; Okamoto I; Taima K; Ebi N; Daga H; Yamasaki A; Kodani M; Udagawa H; Kirita K; Zenke Y; Nosaki K; Sugiyama E; Sakai T; Nakai T; Ishii G; Niho S; Ohtsu A; Kobayashi SS; Goto K
Nature; 2021 Dec; 600(7888):319-323. PubMed ID: 34819663
[TBL] [Abstract][Full Text] [Related]
12. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
[TBL] [Abstract][Full Text] [Related]
13. Small-cell transformation of
Balla A; Khan F; Hampel KJ; Aisner DL; Sidiropoulos N
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29317428
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of Cell-Free DNA for the Detection of
McCoach CE; Blakely CM; Banks KC; Levy B; Chue BM; Raymond VM; Le AT; Lee CE; Diaz J; Waqar SN; Purcell WT; Aisner DL; Davies KD; Lanman RB; Shaw AT; Doebele RC
Clin Cancer Res; 2018 Jun; 24(12):2758-2770. PubMed ID: 29599410
[No Abstract] [Full Text] [Related]
15. GPC1-ALK: A novel ALK fusion in a patient with pulmonary sarcomatoid carcinoma.
Xiong L; Li X; Chen D; Li S; Luo L
Lung Cancer; 2021 Jan; 151():104-105. PubMed ID: 33277054
[No Abstract] [Full Text] [Related]
16. ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.
McLeer-Florin A; Duruisseaux M; Pinsolle J; Dubourd S; Mondet J; Phillips Houlbracq M; Magnat N; Fauré J; Chatagnon A; de Fraipont F; Giaj Levra M; Toffart AC; Ferretti G; Hainaut P; Brambilla E; Moro-Sibilot D; Lantuejoul S
Lung Cancer; 2018 Feb; 116():15-24. PubMed ID: 29413046
[TBL] [Abstract][Full Text] [Related]
17. Concordance Analysis of ALK Gene Fusion Detection Methods in Patients with Non-Small-Cell Lung Cancer from Chile, Brazil, and Peru.
Sepúlveda-Hermosilla G; Freire M; Blanco A; Cáceres J; Lizana R; Ramos L; Assar Cuevas R; Ampuero D; Aren O; Chernilo S; Spencer ML; Bernal G; Flores J; Rasse G; Sánchez C; Marcelain K; Rivas S; Branco GP; Galli de Amorim M; Nunes DN; Dias-Neto E; Freitas HC; Fernández C; ; Pérez P; Armisén R
J Mol Diagn; 2021 Sep; 23(9):1127-1137. PubMed ID: 34186175
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Lin C; Shi X; Yang S; Zhao J; He Q; Jin Y; Yu X
Lung Cancer; 2019 May; 131():62-68. PubMed ID: 31027700
[TBL] [Abstract][Full Text] [Related]
19. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
[TBL] [Abstract][Full Text] [Related]
20. ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases.
Fares AF; Lok BH; Zhang T; Cabanero M; Lau SCM; Stockley T; Patel D; Bradbury PA; Sacher A; Yasufuku K; Morash BA; Sabatini PJB; Nguyen LN; Leighl NB; Tsao MS; Shepherd FA; Liu G; Martins-Filho SN; Pal P
Lung Cancer; 2020 Aug; 146():350-354. PubMed ID: 32546380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
